4Filing Date: Jun 18, 2026
Abbott (ABT)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001385262-26-000017
Total Value$173.6K
Trades1
Insiders1
Transaction Details
Stratton John G
Director·Direct
Buy · Acquire
Common shares without par value
Shares+2.00K
Price$86.82
Total Value$173.6K
Shares Owned After23.32K
Transaction DateMay 7, 2026
Post-Transaction Holdings
Stratton John G · Director
| Security | Shares | Change |
|---|---|---|
| Common shares without par value | 23.32K | +2.00K (9.38%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-07
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
--- Reporting Owner ---
Name: Stratton John G
CIK: 0001385262
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common shares without par value
Date: 2026-05-07 | Code: P (Open market purchase)
Shares: +2,000 | Price: $86.82
Total Value: $173,640.00
Shares Owned After: 23,319 | Ownership: D (Direct)
--- Signature ---
/s/ /s/ John G. Stratton by Jessica H. Paik, Attorney-in-Fact (2026-06-18)